Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0000899140-21-000523
Filing Date
2021-06-08
Accepted
2021-06-08 12:44:28
Documents
1
Effectiveness Date
2021-06-08
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 9646
  Complete submission text file 0000899140-21-000523.txt   10745
Mailing Address 375 PARK AVENUE, 28TH FLOOR NEW YORK NY 10152
Business Address 375 PARK AVENUE, 28TH FLOOR NEW YORK NY 10152 212-751-5959
EP Life Sciences L.P. (Filer) CIK: 0001744892 (see all company filings)

EIN.: 830584171 | State of Incorp.: DE
Type: D/A | Act: 33 | File No.: 021-315695 | Film No.: 211001698